港股異動 | 瑞聲科技(2018.HK)漲超6% 前三季度淨利同比增長47.1%
格隆匯11月11日丨瑞聲科技(2018.HK)午後直線拉昇,現報33.85港元,漲6.45%,暫成交4億港元,最新市值409億港元。瑞聲科技今日午間公佈,2021年前9個月,集團實現收入為128.6億元(人民幣,下同),同比上漲4%,毛利率為26.3%,同比上漲3個百分點,淨利潤為11億元,同比上漲47.1%。2021年第三季度收入為42.5億元,同比下降6.1%,毛利率為22.7%,同比下降0.9個百分點;淨利潤為1.83億元,同比下降57.4%。公吿還稱,集團將持續密切關注供應鏈的變化情況,提升內部管理效率,同時靈活管理內部資源以滿足客户需求。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.